GLP-3 (RT)

$69.99

Shipping calculated at checkout.

Available in stock (100)

Triple incretin/glucagon agonist

Retatrutide-class triple agonist targeting the GLP-1, GIP, and glucagon receptor pathways. A 39-amino-acid peptide studied in multi-receptor metabolic signaling research.

For laboratory research use only.

Dosage: 10MG

10MG 20MG

Quantity: 1 Bottle

1 Bottle 2 Bottles 3 Bottles

Free International Shipping over $150
Free Returns Within 7 days

Limited time offer

Don’t miss out on this limited-time advantage crafted for you

GLP-3 (RT)

$69.99

Fast Delivery

7 Days Free Returns

Secure Payment

Research with confidence, supported by clear compound information

For Research Use Only

Lyophilized Peptide

Technical Specifications

Published Research References

Compound Information

Technical specifications

MOLECULAR PROFILE

What Is GLP-3 (RT)?

A triple receptor agonist peptide : a 39-amino-acid synthetic peptide studied across the GIP, GLP-1, and glucagon receptor pathways (GIPR / GLP-1R / GCGR) carrying a C20 fatty diacid chain designed to support albumin binding and extended peptide activity.

Triple Agonist Albumin-Bound

Type Synthetic peptide (triple receptor agonist)

CAS Number 2381089-83-2

Molecular Formula C221H342N46O68

Molecular Weight 4731 g/mol

Amino Acids 39 (backbone)

Fatty Acid Chain C20 diacid (albumin binding)

View on PubChem

STORAGE REQUIREMENTS

Stability Information

Follow appropriate laboratory storage practices to help maintain compound stability.

Freeze for storage Refrigerate after reconstitution Protect from light

Lyophilized Powder -20°C long-term storage

Keep the sealed vial frozen until required for laboratory research.

After Reconstitution 2–8°C refrigerated storage

Maintain consistent refrigeration and avoid unnecessary temperature cycling.

Light Protection Away from direct light

Protect the vial from direct light, excessive heat, and moisture.

01PHASE 2 TRIAL

NEW ENGLAND JOURNAL OF MEDICINE

Triple–Hormone-Receptor Agonist Retatrutide for Obesity

2023 DOI: 10.1056/NEJMoa2301972

Jastreboff AM, et al.

View research

02PHASE 2 TRIAL

THE LANCET

Retatrutide for People with Type 2 Diabetes

2023 Randomised controlled trial

Rosenstock J, et al.

View research

03PHASE 2A TRIAL

NATURE MEDICINE

Retatrutide for Metabolic Dysfunction-Associated Steatotic Liver Disease

2024 Volume 30

Sanyal AJ, et al.

View research

04BODY COMPOSITION

THE LANCET DIABETES & ENDOCRINOLOGY

Effects of Retatrutide on Body Composition in People with Type 2 Diabetes

2025 Phase 2 substudy

Coskun T, et al.

View research

05SCIENTIFIC REVIEW

PUBMED CENTRAL

Triple Agonism Based Therapies for Obesity

2025 PMCID: PMC12304053

Goldney J, et al.

View review

06SCIENTIFIC REVIEW

PUBMED CENTRAL

Retatrutide—A Game Changer in Obesity Pharmacotherapy

2025 PMCID: PMC12190491

Biomolecules review article

View review

07META-ANALYSIS

PUBMED CENTRAL

Efficacy and Safety of Retatrutide in Obesity

2025 PMCID: PMC12026077

Systematic review & meta-analysis

View analysis

08PHASE 3 RESULTS

ELI LILLY AND COMPANY

TRIUMPH-4 Phase 3 Topline Results

2025 Corporate research update

Retatrutide clinical development

View results

09STRUCTURAL BIOLOGY

CELL DISCOVERY

Structural Insights into Triple Agonism at GLP-1R, GIPR and GCGR

2024 Article 77

Li W, Zhou Q, Cong Z, et al.

View research

10COMPOUND RECORD

PUBCHEM

Retatrutide Compound Information

NIH Chemical database record

Identifiers & molecular information

View record

11TRIAL REGISTRY

CLINICALTRIALS.GOV

GLP-3 (RT) Clinical Trials Registry

NIH Active research registry

Study records & trial status

Explore trials

External references are provided for scientific and educational context. GLP-3 (RT) is supplied strictly for laboratory research and is not intended for human or veterinary use.

Research use only notice stating not for human consumption

Primary restriction Not for human consumption.

Intended Research Use

This product is sold exclusively for laboratory research, analytical testing, and educational purposes. It is not intended for human or veterinary use, consumption, administration, diagnosis, treatment, mitigation, cure, or prevention of disease.

Information Disclaimer

Any clinical trial data, technical information, or research findings presented on this page are provided for educational reference only. They should not be interpreted as medical advice, treatment guidance, or product claims.

Purchaser Responsibility

By purchasing this product, you confirm that you are a qualified researcher and will use it responsibly and in accordance with all applicable laws and regulations.

Discover more in our FAQ

1. What is GLP-3 (RT)?

GLP-3 (RT) is a synthetic peptide corresponding to retatrutide. It is characterized by a 39-amino-acid sequence and is studied in laboratory research involving GLP-1, GIP, and glucagon receptor signaling pathways.

2. What makes GLP-3 (RT) different from GLP-1 and GLP-2 research peptides?

GLP-1 peptides are generally associated with a single receptor pathway, while GLP-2 research compounds involve dual-receptor signaling. GLP-3 (RT) is distinguished by its triple-receptor research profile involving GLP-1, GIP, and glucagon receptors.

3. In what form is GLP-3 (RT) supplied?

GLP-3 (RT) is supplied as a lyophilized, or freeze-dried, peptide powder. Minor differences in the powder’s appearance may occur between vials and do not necessarily indicate a difference in the labeled material.

4. Where can I find additional information about retatrutide?

Additional information can be reviewed through the scientific publications, compound databases, and clinical trial records referenced on this product page. These external resources provide further background on retatrutide and its research history.

5. What is GLP-3 (RT) intended for?

GLP-3 (RT) is intended strictly for in-vitro laboratory research, analytical testing, and educational research purposes. It is not intended for human or veterinary use, consumption, administration, diagnosis, or treatment.

Researcher verification

GLP-3 (RT)

GLP-3 (RT)

Research with confidence, supported by clear compound information

Compound Information

What Is GLP-3 (RT)?

Stability Information

Sources & References

Triple–Hormone-Receptor Agonist Retatrutide for Obesity

Retatrutide for People with Type 2 Diabetes

Retatrutide for Metabolic Dysfunction-Associated Steatotic Liver Disease

Effects of Retatrutide on Body Composition in People with Type 2 Diabetes

Triple Agonism Based Therapies for Obesity

Retatrutide—A Game Changer in Obesity Pharmacotherapy

Efficacy and Safety of Retatrutide in Obesity

TRIUMPH-4 Phase 3 Topline Results

Structural Insights into Triple Agonism at GLP-1R, GIPR and GCGR

Retatrutide Compound Information

GLP-3 (RT) Clinical Trials Registry

Important Research Notice

Intended Research Use

Information Disclaimer

Purchaser Responsibility

Discover more in our FAQ

1. What is GLP-3 (RT)?

2. What makes GLP-3 (RT) different from GLP-1 and GLP-2 research peptides?

3. In what form is GLP-3 (RT) supplied?

4. Where can I find additional information about retatrutide?

5. What is GLP-3 (RT) intended for?

Shop

Support

Legal

Your cart

Order note

Estimate Shipping

Coupon

GLP-3 (RT)

GLP-3 (RT)

GLP-3 (RT)

Research with confidence, supported by clear compound information

What Is GLP-3 (RT)?

Stability Information

Triple–Hormone-Receptor Agonist Retatrutide for Obesity

Retatrutide for People with Type 2 Diabetes

Retatrutide for Metabolic Dysfunction-Associated Steatotic Liver Disease

Effects of Retatrutide on Body Composition in People with Type 2 Diabetes

Triple Agonism Based Therapies for Obesity

Retatrutide—A Game Changer in Obesity Pharmacotherapy

Efficacy and Safety of Retatrutide in Obesity

TRIUMPH-4 Phase 3 Topline Results

Structural Insights into Triple Agonism at GLP-1R, GIPR and GCGR

Retatrutide Compound Information

GLP-3 (RT) Clinical Trials Registry

Intended Research Use

Information Disclaimer

Purchaser Responsibility

Discover more in our FAQ

1. What is GLP-3 (RT)?

2. What makes GLP-3 (RT) different from GLP-1 and GLP-2 research peptides?

3. In what form is GLP-3 (RT) supplied?

4. Where can I find additional information about retatrutide?

5. What is GLP-3 (RT) intended for?

Your cart (0)

Order note

Estimate Shipping

Coupon

Product Comparison

GLP-3 (RT)

Choose your option

Your cart